Literature DB >> 3321102

Metabolism and reactions of quinoid anticancer agents.

G Powis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3321102     DOI： 10.1016/0163-7258(87)90105-7

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  29 in total

1.  Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling.

Authors:  Chao Yan; David Siegel; Jeffery Newsome; Aurelie Chilloux; Christopher J Moody; David Ross
Journal:  Mol Pharmacol       Date:  2011-12-06       Impact factor: 4.436

2.  Cell damage by oxygen free radicals.

Authors:  G Bellomo
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

Review 3.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 4.  Cytochromes P450 and drug resistance.

Authors:  J Doehmer; A R Goeptar; N P Vermeulen
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 5.  Cellular pharmacology of quinone bioreductive alkylating agents.

Authors:  S Rockwell; A C Sartorelli; M Tomasz; K A Kennedy
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

6.  Aminopyrimidoisoquinolinequinone (APIQ) redox cycling is potentiated by ascorbate and induces oxidative stress leading to necrotic-like cancer cell death.

Authors:  David R Vásquez; Julien Verrax; Jaime A Valderrama; Pedro Buc Calderon
Journal:  Invest New Drugs       Date:  2011-04-05       Impact factor: 3.850

7.  Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery.

Authors:  Daniel R Crooks; Manik C Ghosh; Ronald G Haller; Wing-Hang Tong; Tracey A Rouault
Journal:  Blood       Date:  2009-11-25       Impact factor: 22.113

Review 8.  Bioreductive activation of quinones: a mixed blessing.

Authors:  A S Koster
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

9.  Comparative metabolism and pharmacokinetics of doxorubicin and 4'-epidoxorubicin in plasma, heart and tumor of tumor-bearing mice.

Authors:  W J van der Vijgh; P A Maessen; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 10.  DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.

Authors:  D Ross; D Siegel; H Beall; A S Prakash; R T Mulcahy; N W Gibson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.